A Study of Longer Interval of IVT IBI302 in Subjects With nAMD

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The study is designed for multi-center, randomized, double-masked, active-controlled study to evaluate the longer interval of intravitreal injection of IBI302 in subjects with neovascular age-related macular degeneration.
Epistemonikos ID: 4ce77c1d9cbf6992f3876dbc13afbe7a23f4eac6
First added on: May 13, 2024